GRK4 (G Protein-Coupled Receptor Kinase 4), a paralog for GRK5, has been associated with AD pathology (Guimaraes et al., 2021) and is a potential drug target (Zhang et al., 2022). The gene discussed is GRK5; the disease is Alzheimer disease.